The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,557 | 94,200 | SH | SOLE | 94,200 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 64 | 22,236 | SH | SOLE | 22,236 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 30,816 | 738,451 | SH | SOLE | 738,451 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 19,147 | 920,550 | SH | SOLE | 920,550 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 61,286 | 12,331,130 | SH | SOLE | 12,331,130 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 11,102 | 77,223 | SH | SOLE | 77,223 | 0 | 0 | ||
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 47,749 | 3,838,376 | SH | SOLE | 3,838,376 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 146,079 | 16,618,776 | SH | SOLE | 16,618,776 | 0 | 0 | ||
ARRAY BIOPHARMA INC | NOTE 3.000% 6/0 | 04269XAA3 | 12,593 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 37,927 | 2,670,942 | SH | SOLE | 2,670,942 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 15,214 | 832,736 | SH | SOLE | 832,736 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 77 | 36,743 | SH | SOLE | 36,743 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 9,939 | 459,505 | SH | SOLE | 459,505 | 0 | 0 | ||
CASTLIGHT HEALTH INC | CL B | 14862Q100 | 51 | 10,229 | SH | SOLE | 10,229 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 29,193 | 516,598 | SH | SOLE | 516,598 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 18,827 | 247,107 | SH | SOLE | 247,107 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 15,391 | 3,345,959 | SH | SOLE | 3,345,959 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 71,976 | 1,620,355 | SH | SOLE | 1,620,355 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 7,660 | 696,992 | SH | SOLE | 696,992 | 0 | 0 | ||
DIPLOMAT PHARMACY INC | COM | 25456K101 | 1,932 | 153,317 | SH | SOLE | 153,317 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 4,147 | 1,049,791 | SH | SOLE | 1,049,791 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 10,625 | 997,621 | SH | SOLE | 997,621 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 6,903 | 1,206,894 | SH | SOLE | 1,206,894 | 0 | 0 | ||
EXPRESS SCRIPTS HLDG CO | COM | 30219G108 | 23,306 | 338,800 | SH | SOLE | 338,800 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 3,562 | 1,419,058 | SH | SOLE | 1,419,058 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,572 | 316,400 | SH | SOLE | 316,400 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 40,908 | 366,068 | SH | SOLE | 366,068 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 45,321 | 451,987 | SH | SOLE | 451,987 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 8,456 | 1,065,002 | SH | SOLE | 1,065,002 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 6,864 | 228,800 | SH | SOLE | 228,800 | 0 | 0 | ||
ISHARES TR | NASDQ BIOTEC ETF | 464287556 | 1,194 | 4,500 | SH | SOLE | 4,500 | 0 | 0 | ||
MODEL N INC | COM | 607525102 | 7,168 | 809,914 | SH | SOLE | 809,914 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 43,709 | 805,546 | SH | SOLE | 805,546 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 20,916 | 937,957 | SH | SOLE | 937,957 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 34,650 | 1,560,819 | SH | SOLE | 1,560,819 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 18,919 | 260,380 | SH | SOLE | 260,380 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 25,431 | 1,701,049 | SH | SOLE | 1,701,049 | 0 | 0 | ||
PATHEON N V | SHS | N6865W105 | 12,653 | 440,720 | SH | SOLE | 440,720 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 66,365 | 1,040,208 | SH | SOLE | 1,040,208 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 7,733 | 1,578,174 | SH | SOLE | 1,578,174 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 32,157 | 653,725 | SH | SOLE | 653,725 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 39,607 | 1,290,140 | SH | SOLE | 1,290,140 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 2,739 | 180,310 | SH | SOLE | 180,310 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 80,258 | 1,520,904 | SH | SOLE | 1,520,904 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 4,597 | 187,627 | SH | SOLE | 187,627 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 11,533 | 948,440 | SH | SOLE | 948,440 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 291 | 1,820 | SH | SOLE | 1,820 | 0 | 0 | ||
VCA INC | COM | 918194101 | 4,808 | 70,040 | SH | SOLE | 70,040 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 24,887 | 951,712 | SH | SOLE | 951,712 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 26,217 | 996,100 | SH | SOLE | 996,100 | 0 | 0 |